Detalles de la búsqueda
1.
Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial.
Lancet Oncol
; 17(5): 642-50, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27080216
2.
Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
N Engl J Med
; 369(8): 722-31, 2013 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-23964934
3.
Overall Survival Endpoint in Oncology Clinical Trials: Addressing the Effect of Crossover--The Case of Pazopanib in Advanced Renal Cell Carcinoma.
Oncology
; 90(3): 119-26, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26901053
4.
A randomized and open-label trial evaluating the addition of pazopanib to lapatinib as first-line therapy in patients with HER2-positive advanced breast cancer.
Breast Cancer Res Treat
; 137(3): 755-66, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23283526
5.
Phase I and pharmacokinetic study of pazopanib and lapatinib combination therapy in patients with advanced solid tumors.
Invest New Drugs
; 31(3): 751-9, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23054212
6.
Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials.
Lancet Oncol
; 13(8): 827-37, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22759480
7.
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial.
J Clin Oncol
; 41(11): 1957-1964, 2023 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37018920
8.
Association of the hemochromatosis gene with pazopanib-induced transaminase elevation in renal cell carcinoma.
J Hepatol
; 54(6): 1237-43, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21145803
9.
A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors.
Invest New Drugs
; 29(3): 467-72, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20069338
10.
A phase I and pharmacokinetic study of lapatinib in combination with letrozole in patients with advanced cancer.
Clin Cancer Res
; 14(14): 4484-90, 2008 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18628463
11.
Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study.
Cancer Chemother Pharmacol
; 62(5): 911-9, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18301896
12.
Phase I pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) in patients with solid tumors.
Clin Cancer Res
; 13(15 Pt 1): 4495-502, 2007 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17671135
13.
Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma.
Cancer Discov
; 8(8): 944-957, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29891538
14.
Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer.
Clin Cancer Res
; 12(14 Pt 1): 4265-73, 2006 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16857801
15.
Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034).
Blood
; 113(19): 4819-20, 2009 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-19423744
16.
Is change in blood pressure a biomarker of pazopanib and sunitinib efficacy in advanced/metastatic renal cell carcinoma?
Eur J Cancer
; 53: 96-104, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26702763
17.
HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer.
Clin Cancer Res
; 22(6): 1371-7, 2016 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26546620
18.
A phase I study of cantuzumab mertansine administered as a single intravenous infusion once weekly in patients with advanced solid tumors.
Clin Cancer Res
; 10(13): 4363-8, 2004 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15240523
19.
Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: a systematic review and meta-analysis of clinical trials in advanced cancer patients.
Eur J Cancer
; 51(10): 1293-302, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25899987
20.
Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trial.
Clin Cancer Res
; 21(5): 1071-7, 2015 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25538263